Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Others); By Type; By End-Use; By Region; Segment Forecast, 2022 - 2030
... size is expected treach USD 56.92 Billion by 2030 according ta new study by Polaris Market Research. The report “Blood Plasma Market Share, Size, Trends, Industry Analysis Report, By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von ... Read More
-
2022 Global Forecast for Anemia Drugs Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Chemotherapy Induced Anemia (Toxicology) pipeline landscape. Chemotherapy-induced anemia is a very common side effect of cancer treatment. Symptoms include severe fatigue, weakness, anxiety, lack of energy, shortness of ... Read More
-
Middle East and Turkey Hemophilia Treatment Market, by Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Desmopressin), by Disease Indication (Hemophilia A, Hemophilia B, and Hemophilia C), and b
... Egypt, Israel, Saudi Arabia, UAE, and Rest of Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Hemophilia is rare disorder, in which in which the blood does not clot properly. In ... Read More
-
Hemophilia Treatment Market, by Product Type (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Antifibrinolytic Agents, and Desmopressin), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Onl
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Hemophilia, a factor VIII deficiency, is a genetic disorder that is caused by the absence of the ... Read More
-
Lentiviral Vectors Market, By Product Type (1st-generation, 2nd-generation, and 3rd-generation), By Indication (HIV, β-thalassemia, X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy, and Wiskott-Aldrich Syndrome), By End User (Hospitals, Clinics
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Lentiviral vectors are potential gene transfer vehicles used in both research and gene therapy applications. Lentiviral vectors ... Read More
-
Hemophilia Gene Therapy Market - Size, Share, Trends, and Forecast, 2022 - 2028
... factors. Conventional treatment options include timely replacement of the specific clotting factor. Major pharma and biotech companies are conducting research and development to develop gene therapy for hemophilia due to various shortcomings with conventional therapy. ... Read More
-
Hemophilia Treatment Market - Global Industry Analysis (2019 - 2021) - Growth Trends and Market Forecast (2022 - 2027)
... a rare disease, hemophilia occurs due to the absence/lack of a protein known as a clotting factor. It is divided into three main types namely, Hemophilia A, Hemophilia B, and Acquired Hemophilia. Owing to the ... Read More
-
2022 Global: Plasma Fractionation - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
Thalassemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms include fussiness, paleness, frequent infections, failure ... Read More
-
Global Biosimilars Market Size study, By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Calcitonin), By Indication (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2022-2028
... Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2022-2028 Global Biosimilars Market is valued at approximately USD 15.60 Billion in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
Blood and Blood Components Market Size By Product (Whole Blood, Blood Components {Red Blood Cells, Platelets, Plasma, White Blood Cells}), By Application (Anaemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders), By End-Use (Hospitals, Ambulatory Surgical Centres), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
... Centres), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028 The blood and blood components market is expected to gain impetus through 2028 owing ... Read More
-
Iron Deficiency Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Iron Deficiency Anemia (Hematological Disorders) pipeline landscape. Anemia is a condition in which the body does not ... Read More
-
Global Hypereosinophilic Syndrome Market - 2022-2029
... of XX% during the forecast period (2022-2029). Hypereosinophilic syndrome (HES) is characterized by an abnormally high eosinophil count in the blood. Eosinophils are white blood cells that play an important role in the immune system. ... Read More
-
2022 Global Forecast for Plasma Fractionation (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Chemotherapy Induced Anemia - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Chemotherapy Induced ... Read More
-
Hemophilia Treatment Market
... important market dynamics. After conducting thorough research on the historical and current growth parameters of the Hemophilia Treatment System Market, the growth prospects of the market are obtained with maximum precision. Market Segmentation The Hemophilia ... Read More
-
Global Hemophilia Market: Size, Trends & Forecast with Impact of COVID-19 (2022-2026)
... global hemophilia market by value, by number of identified patient, by severity, by therapy type, by region (North America (The US and rest of the North America), Europe, Asia Pacific, and Rest of the World), ... Read More
-
Blood Plasma Derivatives Market by Product Type (Albumin, Anti-inhibitor Coagulation Factor, Factor VIII, Factor IX Concentrate, Immunoglobulins, Rh Immunoglobulin, Alpha 1-Protaese Inhibitor, and Anti–Thrombin), Application (HIV, Hemophilia A, Hemophilia B, Hepatitis C, Bleeding Disorders, Genetic Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global blood plasma derivatives market was valued at ... Read More
-
Hemophilia Treatment Market Size By Disease (Hemophilia A {Severe, Moderate, Mild}, Hemophilia B {Severe, Moderate, Mild}), By Product (Recombinant Factor Concentrates {Factor VIII, Factor IX}, Plasma-derived Factor Concentrates {Factor VIII, Factor IX}, Extended Half-life Products {Factor VIII, Factor IX}), By Patient (Pediatric {0 to 4, 5 to 13, 14 to18}, Adult {19 to 44, 45+}), By Treatment (Prophylaxis, On Demand), By Therapy (Factor Replacement Therapy, Non-factor Replacement Therapy), By Drug Class (Vasopressin, Coagulation Factors), By Route of Administration (Injectable, Nasal Spray), By End-use (Hospitals, Clinics, Hemophilia Treatment Centers), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... {Factor VIII, Factor IX}), By Patient (Pediatric {0 to 4, 5 to 13, 14 to18}, Adult {19 to 44, 45+}), By Treatment (Prophylaxis, On Demand), By Therapy (Factor Replacement Therapy, Non-factor Replacement Therapy), By Drug ... Read More
-
Plasma Derived Medicine Market, by Product Type (Albumin, Coagulation factors, Immunoglobulins, and Others), by Indication (Pelvic Inflammatory Disease (PID), Bleeding Disorders, Alpha-1 Antitrypsin Deficiency (AATD), Hereditary Angioedema (HAE), Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Multifocal Motor Neuropathy, Liver Diseases, Primary Immune Thrombocytopenia, Infections, and Other Orphan Diseases), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Motor Neuropathy, Liver Diseases, Primary Immune Thrombocytopenia, Infections, and Other Orphan Diseases), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and ... Read More
-
Blood And Blood Components Global Market Report 2022 Including: 1) By Product: Whole Blood; Blood Components 2) By End-Users: Hospitals; Ambulatory Surgical Centers; Others 3) By Application: Anemia; Trauma & Surgery; Cancer Treatment; Bleeding Disorders 4) By Blood Components: Red Blood Cells; Platelets; Plasma; White Blood Cells Covering: American Red Cross; Australian Red Cross Blood Service; Abbott Laboratories; Blood Centers of America; Becton
... report focuses on the blood and blood components market which is experiencing strong growth. The report gives a guide to the blood and blood components market which will be shaping and changing our lives over ... Read More
-
Stem Cell/Cord Blood Banking Global Market Report 2022 Including: 1) By Cell Type: Adult Stem Cells; Umbilical Cord Blood Stem Cells; Embryonic Stem Cells 2) By Service: Collection; Processing; Analysis; Storage 3) By Bank Type: Public; Private 4) By Application: Leukemia; Anemia; Thalassemia; Autism; Cerebral Palsy; Diabetes; Others Covering: AMAG Pharmaceuticals; Cordlife; Cryo-Cell International; Esperite; Americord Registry LLC; China Cord Blood Corporation
... report focuses on the stem cell/cord blood banking market which is experiencing strong growth. The report gives a guide to the stem cell/cord blood banking market which will be shaping and changing our lives over ... Read More
-
Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Blood, Lung, Colorectal Cancer, Neurology Diseases), End User (Pharma Companies, CROs), Region - Global Forecast to 2026
... global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6% during the forecast period. Market growth is driven by factors such ... Read More
-
Chemotherapy Induced Anemia - Market Insight, Epidemiology And Market Forecast - 2032
... the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chemotherapy-induced anemia market report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted Chemotherapy-induced ... Read More
Research Assistance
